The Diagnostic Value of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPeking University Third Hospital
About this trial
The goal of this observational study is to quantitatively assess the renal microcirculation changes by contrast-enhanced ultrasound (CEUS) and to obtain systemic hemodynamic information by ultrasound Doppler at the same time, to analyze the relationship between renal microcirculation changes and systemic hemodynamic changes, and to explore the diagnostic value of CEUS in critically ill acute kidney injury.
Eligibility criteria
Qualifiers
Age>18 years old
First admission to ICU < 24h after admission and expected ICU stay ≥48 hours
Acute kidney injury risk factors (KDIGO 2012)
Contrast-enhanced ultrasound
Disqualifiers
Known severe chronic kidney disease (CKD≥ stage 4) or undergoing hemodialysis treatment
Kidney transplantation or renal malignancy
Terminal stage of malignant tumor
Pregnancy
Trial design
Treatments tested in this trial
- Contrast-enhanced Ultrasound
Treatment groups
60 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov